Arformoterol Tartrate Patent Expiration
Arformoterol Tartrate is Used for maintenance treatment of bronchoconstriction in patients with COPD. It was first introduced by Lupin Inc
Arformoterol Tartrate Patents
Given below is the list of patents protecting Arformoterol Tartrate, along with the drug name that holds that patent and the company name owning that drug.
Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
---|---|---|---|---|
Brovana | US6472563 | Formoterol tartrate process and polymorph |
Nov 09, 2021
(Expired) | Lupin |
Brovana | US6720453 | Formoterol tartrate polymorph |
Nov 09, 2021
(Expired) | Lupin |
Brovana | US7145036 | Formoterol tartrate polymorph |
Nov 09, 2021
(Expired) | Lupin |
Brovana | US8110706 | Formoterol tartrate process and polymorph |
Nov 09, 2021
(Expired) | Lupin |
Brovana | US6667344 | Bronchodilating compositions and methods |
Jun 22, 2021
(Expired) | Lupin |
Brovana | US6814953 | Bronchodilating compositions and methods |
Jun 22, 2021
(Expired) | Lupin |
Brovana | US7348362 | Bronchodilating β-agonist compositions and methods |
Jun 22, 2021
(Expired) | Lupin |
Brovana | US7462645 | Bronchodilating beta-agonist compositions and methods |
Jun 22, 2021
(Expired) | Lupin |
Brovana | US7465756 | Bronchodilating beta-agonist compositions and methods |
Jun 22, 2021
(Expired) | Lupin |
Brovana | US7473710 | Bronchodilating beta-agonist compositions and methods |
Jun 22, 2021
(Expired) | Lupin |
Brovana | US7541385 | Bronchodilating β-agonist compositions and methods |
Jun 22, 2021
(Expired) | Lupin |
Brovana | US6040344 | Formoterol process |
Nov 12, 2016
(Expired) | Lupin |
Brovana | US6589508 | Methods and compositions for treating pulmonary disorders using optically pure (R,R) formoterol |
Apr 03, 2013
(Expired) | Lupin |
Arformoterol Tartrate's Family Patents

Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List